If you love investing in stocks you're bound to buy some losers. But the last three years have been particularly ...
Carl Zeiss Meditech is a subsidiary of Carl Zeiss AG and manufactures tools for eye examination and medical lasers. The company has a strong financial performance with high gross and net margins.
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in ...
A leader in the field of ophthalmic systems was recently formed by the merger of two German companies. Asclepion-Meditec AG and Carl Zeiss Ophthalmic Systems AG, the ophthalmic unit of the Carl Zeiss ...
Carl Zeiss Meditec has seen a decline in its stock price, along with other high-valued companies, due to the commoditization of premium stocks. The company has impressive products, high gross margins, ...
Please provide your email address to receive an email when new articles are posted on . Two new Carl Zeiss Meditec ophthalmic systems and recent innovations to existing ocular technologies were ...
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Carl Zeiss Meditec AG (ETR:AFX) is about to go ex-dividend ...
Optovue and Carl Zeiss Meditec Have Reached Settlement in Their Current Patent Infringement Disputes
FREMONT, Calif. & DUBLIN, Calif.--(BUSINESS WIRE)--Optovue Inc. and Carl Zeiss Meditec Inc. announced today that they have signed a settlement agreement resolving two pending Federal District Court ...
(RTTNews) - Carl Zeiss Meditec AG (CZMWF.PK) said Thursday that Ludwin Monz, who has been Chief Executive Officer of the company since 2010, will hand over his position to Markus Weber, currently ...
Acquisition will extend the company's leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment D.O.R.C., a leading player in the retinal surgical ...
Carl Zeiss Meditec, the medical technology subsidiary of optics giant Carl Zeiss, has posted a 19.4% increase in profits for the year ended September 30, following strong sales performance and reduced ...
Oraya Therapy represents an attractive new treatment option for patients. Carl Zeiss Meditec AG and Oraya Therapeutics, Inc. (Oraya) jointly announced that the companies have entered into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results